223
Participants
Start Date
March 1, 2022
Primary Completion Date
October 1, 2023
Study Completion Date
January 1, 2024
Esketamine
In the esketamine combined with butorphanol group (Group BK), patients received an intraoperative intravenous infusion of esketamine (0.3 mg/kg/h) followed by postoperative patient-controlled intravenous analgesia (PCIA) (esketamine 1.5 mg/kg + butorphanol 0.15 mg/kg + azasetron 20 mg).
Butorphanol
In the butorphanol group (Group B), patients received an equivalent volume of normal saline intraoperatively and postoperatively received PCIA without esketamine.
The Second People's Hospital of Hefei, Hefei
Tongji Hospital
OTHER
Second People's Hospital of Hefei City
OTHER